HIGHLIGHTS
- who: . et al. from the Phanes Therapeutics, Inc, United States College of Pharmacy, Chongqing Medical University, Chongqing, China, Phase I Clinical Research have published the research work: Factors in fl uencing bioequivalence evaluation of insulin biosimilars based on a structural equation model, in the Journal: (JOURNAL)
- what: The authors aimed to explore the factors affecting the bioequivalence of two preparations using a multiple statistical model, thus providing a scientific basis for the review and approval of insulin biosimilars.
- how: The authors carried out the trial in accordance with the principles of the Declaration . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.